A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants

Clinical trial NCT06619483 · COMPLETED

Trial details

NCT number: NCT06619483
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Venous and Arterial Thrombotic and Thromboembolic Events Healthy Volunteers

Start date: 2024-10-10
Primary completion: 2025-01-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.